| Literature DB >> 35899092 |
Allison C Morphis1, Stacey L Edwards1, Purevsuren Erdenebat1, Lalit Kumar1, Jian Li1.
Abstract
HSF-1 is a key regulator of cellular proteotoxic stress response and is required for animal lifespan. In C. elegans, HSF-1 mediated heat shock response (HSR) declines sharply on the first day of adulthood, and HSF-1 was proposed to function primarily during larval stages for lifespan assurance based on studies using RNAi. The tissue requirement for HSF-1 in lifespan, however, is not well understood. Using the auxin-inducible degron (AID) system, we manage to uncouple the roles of HSF-1 in development and longevity. In wild-type animals, we find HSF-1 is required during the whole self-reproductive period for lifespan. This period is extended in long-lived animals that have arrested germline stem cells (GSC) or reduced insulin/IGF-1 signaling (IIS). While depletion of HSF-1 from any major somatic tissues during development results in severe defects, HSF-1 primarily functions in the intestine and likely neural system of adults to support lifespan. Finally, by combining AID and genome-wide transcriptional analyses, we find HSF-1 directly activates the transcription of constitutively-expressed chaperone and co-chaperone genes among others in early adulthood, which underlies its roles in longevity assurance.Entities:
Keywords: aging; auxin-inducible degron; core chaperome; heat shock factor; lifespan; proteostasis; temporal-spatial function
Year: 2022 PMID: 35899092 PMCID: PMC9309338 DOI: 10.3389/fragi.2022.899744
Source DB: PubMed Journal: Front Aging ISSN: 2673-6217
FIGURE 1Temporal requirement for HSF-1 in lifespan. Lifespan analysis at 20°C upon pan-somatic depletion of HSF-1 by AID using 1 mM of auxin (A) or 0.5 mM of auxin (B). The control strain, CA1200 (eft-3p:tir1) was mock treated with ethanol (EtOH) or treated with auxin from Day 1 of adulthood. The HSF-1 AID model, JTL611 (eft-3p:tir1; hsf-1:degron) were mock treated with ethanol (EtOH) from Day 1 of adulthood or transferred from EtOH to auxin plates at indicated time to initiate HSF-1 depletion.
The lifespan data and statistical test upon pan-somatic HSF-1 depletion in the wild-type background, related to Figure 1.
| Trial | Strain, treatment | Median Lifespan (Days of adulthood) | S.E. | Observed/Total | % Lifespan change |
|
|---|---|---|---|---|---|---|
| #1, 20°C | CA1200 (eft-3p::tir1), control | 15.69 | 0.38 | 89/101 | ||
| CA1200 (eft-3p::tir1), 1mM auxin | 14.92 | 0.35 | 83/99 | −4.91 | 0.098 | |
| #2, 20°C | CA1200 (eft-3p::tir1), control | 15.71 | 0.41 | 117/130 | ||
| CA1200 (eft-3p::tir1), 1mM auxin | 17.74 | 0.47 | 110/130 | 12.92 | 0.0004 | |
| CA1200 (eft-3p::tir1), control | 16.25 | 0.43 | 98/130 | |||
| CA1200 (eft-3p::tir1), 0.5mM auxin | 17.02 | 0.42 | 117/130 | 4.74 | 0.0453 | |
| #1, 20°C | JTL611 (eft-3p::tir1; hsf-1::degron), control | 14.94 | 0.37 | 95/108 | ||
| JTL611, 1mM auxin (Day 1) | 9.87 | 0.11 | 90/120 | −33.94 | <1e-8 | |
| JTL611, 1mM auxin (Day 2) | 11.65 | 0.15 | 95/120 | −22.02 | <1e-8 | |
| JTL611, 1mM auxin (Day 3) | 12.84 | 0.17 | 102/120 | −14.06 | <1e-8 | |
| JTL611, 1mM auxin (Day 4) | 13.43 | 0.2 | 119/120 | −10.11 | 4.4e-8 | |
| JTL611, 1mM auxin (Day 5) | 14.3 | 0.25 | 109/120 | −4.28 | 0.0005 | |
| #2, 20°C | JTL611 (eft-3p::tir1; hsf-1::degron), control | 16.39 | 0.39 | 94/100 | ||
| JTL611, 0.5mM auxin (Day 1) | 9.65 | 0.16 | 110/120 | −41.12 | <1e-8 | |
| JTL611, 0.5mM auxin (Day 2) | 12.77 | 0.16 | 116/120 | −22.09 | <1e-8 | |
| JTL611, 0.5mM auxin (Day 3) | 13.46 | 0.2 | 113/120 | −17.88 | <1e-8 | |
| JTL611, 0.5mM auxin (Day 4) | 14.56 | 0.22 | 117/120 | −11.17 | 2.4e-7 | |
| JTL611, 0.5mM auxin (Day 5) | 15.05 | 0.29 | 112/120 | −8.18 | 0.0006 |
FIGURE 2Temporal requirement for HSF-1 in lifespan extension by GSC arrest. (A,B) Lifespan analysis at 25°C upon pan-somatic depletion of HSF-1 by AID in the control fem-3(q20) (A) or the long-lived glp-1(e2141) background (B). Animals were mock treated with ethanol (EtOH) from Day 1 of adulthood or treated with auxin starting at the indicated time. (C,D) Lifespan analysis at 25°C upon pan-somatic depletion of HSF-1 by AID when fed with carbenicillin-treated OP50 bacteria. Animals were mock treated with ethanol (EtOH) since Day 1 of adulthood as controls. HSF-1 depletion was initiated in the long-lived glp-1(e2141) background at the indicated time (C), or a comparison was made between the fem-3(q20) and glp-1(e2141) when both had HSF-1 depleted since Day 1 of adulthood (D).
The lifespan data and statistical test upon pan-somatic HSF-1 depletion in long-lived animals, related to Figure 2 and Supplementary Figure S2.
| Trial without antibiotic | Strain, treatment | Median lifespan (Days of adulthood) | S.E. | Observed/Total | % Lifespan change |
|
|---|---|---|---|---|---|---|
| #1, 25°C | JTL623 (glp-1; eft-3p::tir1), control | 13.42 | 0.56 | 115/120 | ||
| JTL623 (glp-1; eft-3p::tir1), 1mM auxin (Day 1) | 13.97 | 0.46 | 116/120 | 4.10 | 3.20E-01 | |
| JTL667 (glp-1; eft-3p::tir1; hsf-1::degron), control | 13.12 | 0.38 | 114/120 | |||
| JTL667 (glp-1; eft-3p::tir1; hsf-1::degron), 1mM auxin (Day 1) | 6.98 | 0.08 | 116/120 | −46.80 | <1e-8 | |
| JTL667 (glp-1; eft-3p::tir1; hsf-1::degron), 1mM auxin (Day 2) | 8.21 | 0.14 | 116/120 | −37.42 | <1e-8 | |
| JTL667 (glp-1; eft-3p::tir1; hsf-1::degron), 1mM auxin (Day 3) | 9.38 | 0.2 | 117/120 | −28.51 | <1e-8 | |
| JTL667 (glp-1; eft-3p::tir1; hsf-1::degron), 1mM auxin (Day 4) | 10.28 | 0.2 | 120/120 | −21.65 | <1e-8 | |
| #1, 25°C | JTL624 (fem-3; eft-3p::tir1), control | 9.23 | 0.15 | 114/120 | ||
| JTL624 (fem-3; eft-3p::tir1), 1mM auxin (Day 1) | 9.15 | 0.17 | 115/120 | −0.87 | 8.48E-01 | |
| JTL670 (fem-3; eft-3p::tir1; hsf-1::degron), control | 9.44 | 0.16 | 118/120 | |||
| JTL670 (fem-3; eft-3p::tir1; hsf-1::degron), 1mM auxin (Day 1) | 6.61 | 0.07 | 120/121 | −29.98 | <1e-8 | |
| JTL670 (fem-3; eft-3p::tir1; hsf-1::degron), 1mM auxin (Day 2) | 7.77 | 0.09 | 120/120 | −17.69 | <1e-8 | |
| JTL670 (fem-3; eft-3p::tir1; hsf-1::degron), 1mM auxin (Day 3) | 7.92 | 0.11 | 119/120 | −16.10 | <1e-8 | |
| JTL670 (fem-3; eft-3p::tir1; hsf-1::degron), 1mM auxin (Day 4) | 8.45 | 0.13 | 116/120 | −10.49 | 1.30E-05 |
FIGURE 3Transcriptional program of HSF-1 in the soma of young adults. (A) G browser views of HSF-1 and RNA Polymerase II (Pol II) occupancy at the Y94H6A.10 and hsp-1 (hsc-70) gene loci in young adults grown at the ambient temperature of 20°C with either the mock treatment (ctrl) or an acute HSF-1 depletion (depl) from the soma (soma) or the germline (germ) (auxin treatment for 2 h). (B) Heatmaps of Pol II occupancy changes upon HSF-1 depletion in young adults from the soma for 2 h and mRNA changes by HSF-1 depletion for 24 h at differentially expressed (DE) genes. The data shown are based on ChIP-seq and RNA-seq experiments in JTL611 (wild-type background). The DE genes are those that significantly altered mRNA levels (FDR: 0.05) upon pan-somatic depletion of HSF-1 for 24 h (Supplementary Table S2). Pol II occupancy change was calculated as the difference of normalized ChIP-seq reads (HSF-1 depletion vs. the control) mapped in 50 bp bins, ±500 bp from the transcription start sites (TSS) and transcription termination site (TTS). The fold change (FC) of Pol II occupancy (2 h of HSF-1 depletion) and mRNA (24 h of HSF-1 depletion) are shown in the log2 scale. The DE genes were first ranked by fold change of mRNA and then by whether bound by HSF-1 at the promoters (1 kb from TSS). The number of DE genes in each group is shown in parentheses. (C) The gene network is directly activated by HSF-1 in the somatic cells from glp-1(e2141). Genes included are those with HSF-1 binding peaks at the promoters and significantly decreased expression upon HSF-1 depletion from the soma for 8 h or 24 h on Day 1 of adulthood. The protein-protein interaction network was retrieved from the STRING database and grouped by kmeans clustering (n = 3). The node color represents the cluster to which the gene belongs. The color saturation of edges represents the confidence score of functional interaction. Genes with names in black encode chaperones or co-chaperones, and genes with names in red are those with other functions. (D,E) Gene Ontology (GO) analyses of DE genes by HSF-1 depletion from the soma in glp-1(e2141) for 24 h (D) and 48 h (E). The top5 GO terms based on enrichment score are shown for down-regulated genes (blue bars) and up-regulated genes (red bars) respectively. (F) Quantification of immunofluorescence of ubiquitinylated proteins in the control group or upon HSF-1 depletion from the soma since Day 1 of adulthood for 48 h in glp-1(e2141). Data are shown as mean ± standard deviation (n>=12). Only animals with clear staining by the control antibody against REC-8 were included in analyses. Statistical significance was calculated by unpaired, two-tailed Student’s t test. *p < 0.05.
FIGURE 4Different tissue requirements for HSF-1 in larval development and lifespan assurance. (A) Size tracking of developing larvae with continuous HSF-1 depletion in the hypodermis initiated at egg lay. Experiments were done in the wild-type background at 20°C. Data are represented as mean ± standard deviation (n>=12). p < 0.0001 (control vs. HSF-1 depletion, two-way ANOVA). (B) Mobility of developing larvae measured as body length per second with continuous HSF-1 depletion in the muscle initiated at egg lay. Experiments were done in the wild-type background at 20°C. Data are represented as mean ± standard deviation (n>=12). p < 0.0001 (control vs. HSF-1 depletion, two-way ANOVA). (C–F) Lifespan analysis at 25°C upon depletion of HSF-1 by AID in the intestine (C), neural cells (D), muscle (E), and hypodermis (F) since Day 1 of adulthood. Experiments were done in the control strains (expressing TIR1 only) and HSF1 AID models (expressing TIR1 and having degron insertion at endogenous hsf-1) in the long-lived glp-1(e2141) background. Animals were fed with carbenicillin treated OP50 bacteria and were mock treated with ethanol (EtOH) or treated with auxin since Day 1 of adulthood.
The lifespan data and statistical test upon tissue-specific HSF-1 depletion, related to Figure 4.
| Targeted tissue (with Carbenicillin) | Strain, treatment | Median Lifespan (Days of adulthood) | S.E. | Observed/Total | % Lifespan change |
|
|---|---|---|---|---|---|---|
| Intestine, 25°C | JTL658 (glp-1; ges-1p::tir1), control | 21 | 0.22 | 140/150 | ||
| JTL658 (glp-1; ges-1p::tir1), 1mM auxin (Day 1) | 20.96 | 0.27 | 147/155 | −0.19 | 3.53E-01 | |
| JTL700 (glp-1; ges-1p::tir1; hsf-1::degron), control | 20.47 | 0.34 | 93/100 | |||
| JTL700 (glp-1; ges-1p::tir1; hsf-1::degron), 1mM auxin (Day 1) | 9.05 | 0.11 | 146/150 | −55.79 | <1e-8 | |
| Neural cells, 25°C | JTL659 (glp-1; rab-3p::tir1), control | 21.24 | 0.3 | 145/150 | ||
| JTL659 (glp-1; rab-3p::tir1), 1mM auxin (Day 1) | 21.62 | 0.33 | 142/149 | 1.79 | 2.78E-01 | |
| JTL701 (glp-1; rab-3p::tir1; hsf-1::degron), control | 21.21 | 0.24 | 146/150 | |||
| JTL701 (glp-1; rab-3p::tir1; hsf-1::degron), 1mM auxin (Day 1) | 9.79 | 0.17 | 150/150 | −53.84 | <1e-8 | |
| Muscle, 25°C | JTL660 (glp-1; myo-3p::tir1), control | 20.82 | 0.21 | 146/150 | ||
| JTL660 (glp-1; myo-3p::tir1), 1mM auxin (Day 1) | 21.14 | 0.23 | 143/150 | 1.54 | 2.20E-01 | |
| JTL702 (glp-1; myo-3p::tir1; hsf-1::degron), control | 19.99 | 0.36 | 97/100 | |||
| JTL702 (glp-1; myo-3p::tir1; hsf-1::degron), 1mM auxin (Day 1) | 18.22 | 0.16 | 145/150 | −8.85 | <1e-8 | |
| Hypodermis, 25°C | JTL661 (glp-1; dpy-7p::tir1), control | 20.94 | 0.27 | 140/150 | ||
| JTL661 (glp-1; dpy-7p::tir1), 1mM auxin (Day 1) | 21.95 | 0.28 | 142/150 | 4.82 | 3.10E-03 | |
| JTL703 (glp-1; dpy-7p::tir1; hsf-1::degron), control | 20.84 | 0.25 | 144/150 | |||
| JTL703 (glp-1; dpy-7p::tir1; hsf-1::degron), 1mM auxin (Day 1) | 21.46 | 0.29 | 145/150 | 2.98 | 2.72E-02 |